Importer of Controlled Substances Application: SpecGx LLC, 13783-13784 [2025-05060]
Download as PDF
<![CDATA[
13783
Federal Register / Vol. 90, No. 57 / Wednesday, March 26, 2025 / Notices
Sterling Wisconsin, LLC has
applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed
below for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants, therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before May 27, 2025. Such persons
may also file a written request for a
hearing on the application on or before
May 27, 2025.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.33(a), this
is notice that on January 30, 2025,
Sterling Wisconsin, LLC, W130N10497
Washington Drive, Germantown,
Wisconsin 53022–4448, applied to be
registered as a bulk manufacturer of the
following basic class(es) of controlled
substance(s):
SUMMARY:
Controlled substance
khammond on DSK9W7S144PROD with NOTICES
Lysergic Acid
Diethylamide.
Marihuana Extract ...........
Marihuana ........................
Tetrahydrocannabinols ....
Mescaline ........................
5-Methoxy-N-NDimethyltryptamine.
Psilocybin ........................
Oliceridine ........................
Thebaine ..........................
Alfentanil ..........................
Drug
code
Schedule
7315
I
7350
7360
7370
7381
7431
I
I
I
I
I
7437
9245
9333
9737
I
II
II
II
The company plans to bulk
manufacture the listed controlled
substances for commercial sale to its
customers. In reference to drug codes
7350 (Marihuana Extract), 7360
(Marihuana), and 7370
(Tetrahydrocannabinols), the company
plans to bulk manufacture these drugs
as synthetic. No other activities for these
VerDate Sep<11>2014
16:57 Mar 25, 2025
Jkt 265001
drug codes are authorized for this
registration.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2025–05054 Filed 3–25–25; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
In
accordance with 21 CFR 1301.34(a), this
is notice that on January 27, 2025,
Maridose, LLC, 74 Orion Street, Unit 7,
Brunswick, Maine 04011–5031, applied
to be registered as an importer of the
following basic class(es) of controlled
substance(s):
SUPPLEMENTARY INFORMATION:
Controlled substance
Drug Enforcement Administration
[Docket No. DEA–1517]
Importer of Controlled Substances
Application: Maridose LLC (I)
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Maridose, LLC has applied to
be registered as an importer of basic
class(es) of controlled substance(s).
Refer to SUPPLEMENTARY INFORMATION
listed below for further drug
information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants, therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before April 25, 2025. Such
persons may also file a written request
for a hearing on the application on or
before April 25, 2025.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
SUMMARY:
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
Marihuana Extract ...........
Marihuana ........................
Tetrahydrocannabinols ....
Drug
code
Schedule
7350
7360
7370
I
I
I
The company plans to import the
listed controlled substances for sale to
research facilities for drug testing and
analysis. In reference to drug codes 7360
(Marihuana) and 7370
(Tetrahydrocannabinols) the company
plans to import a synthetic cannabidiol
and a synthetic tetrahydrocannabinol.
No other activities for these drug codes
are authorized for this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2025–05065 Filed 3–25–25; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1516]
Importer of Controlled Substances
Application: SpecGx LLC
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
SpecGx LLC has applied to be
registered as an importer of basic
class(es) of controlled substance(s).
Refer to SUPPLEMENTARY INFORMATION
listed below for further drug
information.
SUMMARY:
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before April 25, 2025. Such
persons may also file a written request
for a hearing on the application on or
before April 25, 2025.
DATES:
E:\FR\FM\26MRN1.SGM
26MRN1
13784
Federal Register / Vol. 90, No. 57 / Wednesday, March 26, 2025 / Notices
The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on February 17, 2025,
SpecGx LLC, 3600 North 2nd Street,
Saint Louis, Missouri 63147–3457,
applied to be registered as an importer
of the following basic class(es) of
controlled substance(s):
ADDRESSES:
Controlled substance
khammond on DSK9W7S144PROD with NOTICES
Phenylacetone .................
Coca Leaves ...................
Thebaine ..........................
Opium, raw ......................
Poppy Straw Concentrate
Tapentadol ......................
Drug
code
Schedule
8501
9040
9333
9600
9670
9780
II
II
II
II
II
II
The company plans to import the
listed controlled substances for bulk
manufacture into Active Pharmaceutical
Ingredients for distribution to its
customers. In reference to Tapentadol
(9780) and Thebaine (9333), the
company plans to import intermediate
forms of these controlled substances for
further manufacturing prior to
distribution to its customers. No other
activities for these drugs are authorized
for this registration. Placement of these
codes onto the company’s registration
does not translate into automatic
approval of subsequent permit
applications to import controlled
substances.
VerDate Sep<11>2014
16:57 Mar 25, 2025
Jkt 265001
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2025–05060 Filed 3–25–25; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
remotely. For security purposes,
members of the public who wish to
participate must register at least seven
(7) days in advance of the meeting/
conference call by contacting Mr. Joy.
Access to the virtual meeting/
conference call will not be allowed
without prior registration. Please submit
any comments or written statements for
consideration by the Review Board in
writing at least seven (7) days in
advance of the meeting date.
Gregory Joy,
Policy Advisor/Designated Federal Officer,
Bureau of Justice Assistance.
[FR Doc. 2025–05052 Filed 3–25–25; 8:45 am]
BILLING CODE 4410–18–P
Office of Justice Programs
[OJP (BJA) Docket No. 1835]
Meeting of the Public Safety Officer
Medal of Valor Review Board
Bureau of Justice Assistance
(BJA), Office of Justice Programs (OJP),
Department of Justice (JUSTICE).
ACTION: Notice of meeting.
AGENCY:
This is an announcement of a
meeting (via WebEx/conference call-in)
of the Public Safety Officer Medal of
Valor Review Board to cover a range of
issues of importance to the Board, to
include but not limited to: Member
terms, program administration,
marketing, and outreach.
DATES: April 29, 2025, 1:30 p.m. to 2:30
p.m. ET.
ADDRESSES: This meeting will be held
virtually using web conferencing
technology. The public may hear the
proceedings of this virtual meeting/
conference call by registering at last
seven (7) days in advance with Gregory
Joy (contact information below). All
emailed requests to register and attend
this meeting must include within its
Subject line, ‘‘MOV Board Meeting
April 29, 2025’’.
FOR FURTHER INFORMATION CONTACT:
Gregory Joy, Policy Advisor, Bureau of
Justice Assistance, Office of Justice
Programs, by telephone at (202) 514–
1369, or by email at Gregory.joy@
usdoj.gov.
SUMMARY:
The
Public Safety Officer Medal of Valor
Review Board carries out those advisory
functions specified in 42 U.S.C. 15202.
Pursuant to 42 U.S.C. 15201, the
President of the United States is
authorized to award the Public Safety
Officer Medal of Valor, the highest
national award for valor by a public
safety officer.
This virtual meeting/conference call
is open to the public to participate
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
NATIONAL LABOR RELATIONS
BOARD
Privacy Act of 1974; System of
Records
National Labor Relations Board
(NLRB).
ACTION: Notice of a new system of
records.
AGENCY:
Pursuant to the provisions of
the Privacy Act of 1974, the National
Labor Relations Board (‘‘NLRB’’ or
‘‘Agency’’) publishes this notice of a
new system of records called ‘‘NLRB
Freedom of Information Act Records
(NLRB–37).’’ The Agency, elsewhere in
the Federal Register, is also publishing
a notice that it is rescinding two systems
of records: NLRB FOIAonline (NLRB–
35); and Freedom of Information Act
Tracking System (FTS) and Associated
Agency Files (NLRB–32). All persons
are advised that, in the absence of
submitted comments considered by the
Agency as warranting modification of
the notice as here proposed, it is the
intention of the Agency that the notice
shall be effective upon expiration of the
comment period without further action.
DATES: Written comments on the
system’s routine uses must be submitted
on or before April 25, 2025. The routine
uses in this action will become effective
on April 25, 2025 unless written
comments are received that require a
contrary determination.
ADDRESSES: All persons who desire to
submit written comments for
consideration by the Agency in
connection with this proposed notice of
the amended system of records shall
mail them to the Agency’s Senior
Agency Official for Privacy, National
Labor Relations Board, 1015 Half Street
SE, Washington, DC 20570–0001, or
submit them electronically to privacy@
nlrb.gov. Comments may also be
SUMMARY:
E:\FR\FM\26MRN1.SGM
26MRN1
]]>Agencies
[Federal Register Volume 90, Number 57 (Wednesday, March 26, 2025)]
[Notices]
[Pages 13783-13784]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-05060]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1516]
Importer of Controlled Substances Application: SpecGx LLC
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: SpecGx LLC has applied to be registered as an importer of
basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY
INFORMATION listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
April 25, 2025. Such persons may also file a written request for a
hearing on the application on or before April 25, 2025.
[[Page 13784]]
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment. All
requests for a hearing must be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152. All requests for a hearing should also be
sent to: Drug Enforcement Administration, Attn: Administrator, 8701
Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on February 17, 2025, SpecGx LLC, 3600 North 2nd Street,
Saint Louis, Missouri 63147-3457, applied to be registered as an
importer of the following basic class(es) of controlled substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Phenylacetone........................... 8501 II
Coca Leaves............................. 9040 II
Thebaine................................ 9333 II
Opium, raw.............................. 9600 II
Poppy Straw Concentrate................. 9670 II
Tapentadol.............................. 9780 II
------------------------------------------------------------------------
The company plans to import the listed controlled substances for
bulk manufacture into Active Pharmaceutical Ingredients for
distribution to its customers. In reference to Tapentadol (9780) and
Thebaine (9333), the company plans to import intermediate forms of
these controlled substances for further manufacturing prior to
distribution to its customers. No other activities for these drugs are
authorized for this registration. Placement of these codes onto the
company's registration does not translate into automatic approval of
subsequent permit applications to import controlled substances.
Approval of permit applications will occur only when the
registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import
of Food and Drug Administration-approved or non-approved finished
dosage forms for commercial sale.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2025-05060 Filed 3-25-25; 8:45 am]
BILLING CODE P
